Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
SPEAKERS: Perry Elliott and Paolo Camici
The ESC Webinars are designed to help you improve your daily practice!
The format includes a case based presentation, online assesssment and live discussions with the two key opinion leaders who will deliver useful tips for your daily clinical practice.
In 2008, The ESC Working Group on Myocardial and Pericardial Diseases proposed an updated classification of cardiomyopathies based on morphological and functional phenotypes and sub-categories of familial/genetic and non-familial/non genetic disease. In this presentation we show how this proposed framework for the clinical approach to diagnosis based on the recognition of diagnostic red flags that can be used to guide rational selection of specialised tests including genetic analysis. The basic premise is that the adoption of a cardiomyopathy specific approach that combines conventional cardiological assessment with non-cardiac and molecular parameters increases diagnostic accuracy and improves advice and treatment for patients and families.
Approximately 25% of patients have obstruction to the LV outflow tract at rest and as many as 70% may have latent or provocable LV outflow tract obstruction caused by contact between the anterior mitral valve leaflet and the ventricular septum during systole. LV outflow tract obstruction is detected using colour flow Doppler and quantified using continuous wave Doppler. Most patients with systolic anterior motion of the mitral valve and LV outflow tract obstruction have a posteriorly directed jet of mitral regurgitation, which can be detected using colour Doppler imaging. The presence of complex mitral regurgitant jets (e.g. anteriorly-directed or central) may indicate the presence of primary mitral valve abnormalities. The mechanisms of obstruction, their assessment and treatment will be reviewed. Factors that determine selection of patients for medical or interventional therapy with surgery, septal alcohol ablation or pacing will be discussed.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P,Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008 Jan;29(2):270-6.
Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, Helio T, Keren A, McKenna WJ, Monserrat L, Pankuweit S, Perrot A, Rapezzi C, Ristic A, Seggewiss H, van Langen I, Tavazzi L; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010 Nov;31(22):2715-26.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
This programme is supported by multiple educational grants including Boehringer Ingelheim and Sanofi in the form of unrestricted educational grants. The ESC Webinar 2012/2013 scientific programme has not been influenced in any way by its sponsors.
© 2017 European Society of Cardiology. All rights reserved